Intratumoral Heterogeneity Determines Discordant Results of Diagnostic Tests for Human Epidermal Growth Factor Receptor (HER) 2 in Gastric Cancer Specimens

Growth Factor ◽

Epidermal Growth Factor ◽

Diagnostic Tests ◽

Growth Factor Receptor ◽

Intratumoral Heterogeneity ◽

Her 2 ◽

An independent survival prognostic role for human epidermal growth factor receptor 2 in gastric cancer: evidence from a meta-analysis

Clinical & Translational Oncology ◽

10.1007/s12094-017-1711-5 ◽

2017 ◽

Vol 20 (2) ◽

pp. 212-220 ◽

Cited By ~ 1

Author(s):

Y. Wang ◽

L. He ◽

Y. Cheng

Keyword(s):

Gastric Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Prognostic Role ◽

Clinical use of trastuzumab combined with different chemotherapy regimens in multi‑line treatment of advanced human epidermal growth factor receptor 2‑positive gastric cancer: A case report

Oncology Letters ◽

10.3892/ol.2018.9212 ◽

2018 ◽

Author(s):

Zhe‑Ling Chen ◽

Andi Zhao ◽

Pan Li ◽

Mi Zhang ◽

Jiao Yang ◽

...

Keyword(s):

Gastric Cancer ◽

Case Report ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Clinical Use ◽

Line Treatment ◽

Erratum: Author’s Affiliation Correction. Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor positive gastric cancer (World J Clin Cases 2019; Aug 6; 7 (15): 1964-1977)

World Journal of Clinical Cases ◽

10.12998/wjcc.v8.i21.5494 ◽

2020 ◽

Vol 8 (21) ◽

pp. 5494-5495

Author(s):

Akio Kaito ◽

Takeshi Kuwata ◽

Masanori Tokunaga ◽

Kohei Shitara ◽

Reo Sato ◽

...

Keyword(s):

Gastric Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Type Ii ◽

Individualized molecular targeted therapy for gastric cancer based on human epidermal growth factor receptor 2 gene detection

World Chinese Journal of Digestology ◽

10.11569/wcjd.v24.i7.1031 ◽

2016 ◽

Vol 24 (7) ◽

pp. 1031

Author(s):

Lian-Xiang Duan ◽

Ai-Guang Zhao ◽

Jian Zheng

Keyword(s):

Gastric Cancer ◽

Targeted Therapy ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Molecular Targeted Therapy ◽

Growth Factor Receptor ◽

Gene Detection ◽

Is there any relationship between Helicobacter pylori infection and human epidermal growth factor receptor 2 expression in gastric cancer?

Journal of Cancer Research and Therapeutics ◽

10.4103/jcrt.jcrt_891_18 ◽

2020 ◽

Vol 16 (8) ◽

pp. 128

Author(s):

Efnan Algin ◽

Meltem Baykara ◽

Guldal Yilmaz ◽

Bulent Cetin ◽

Ozgur Ekinci ◽

...

Keyword(s):

Gastric Cancer ◽

Helicobacter Pylori ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Helicobacter Pylori Infection ◽

Expression of human epidermal growth factor receptor 2 and p53 in gastric cancer patients: Clinical and prognosis relevance

Clinical Cancer Investigation Journal ◽

10.4103/2278-0513.197866 ◽

2016 ◽

Vol 5 (5) ◽

pp. 424

Author(s):

Raja Gargouri ◽

DorraBen Ayed-Guerfali ◽

Najla Abid ◽

Abdelmajid Khabir ◽

Hela Mnif ◽

...

Keyword(s):

Gastric Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Patients ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Gastric Cancer Patients

Significance and prognostic role of human epidermal growth factor receptor 2 and RAB1A expression in gastric cancer

Oncology Letters ◽

10.3892/ol.2018.7992 ◽

2018 ◽

Cited By ~ 4

Author(s):

Bihong Xu ◽

Chunyu Huang ◽

Xianzi Yang ◽

Xiangzhao Li ◽

Liang Li ◽

...

Keyword(s):

Gastric Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Prognostic Role ◽

Abstract 4562: Superior targeting of the human epidermal growth factor receptor 2 (HER-2) with recombinant monoclonal antibody mixtures

10.1158/1538-7445.am2011-4562 ◽

2011 ◽

Cited By ~ 3

Author(s):

Mikkel W. Pedersen ◽

Helle J. Jacobsen ◽

Thomas T. Poulsen ◽

Per J. Meijer ◽

Michael Kragh

Keyword(s):

Monoclonal Antibody ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Recombinant Monoclonal Antibody ◽

Her 2 ◽

Human Epidermal Growth Factor Receptor 2 (HER2) in Advanced Gastric Cancer: Current Knowledge and Future Perspectives

Drugs ◽

10.1007/s40265-020-01272-5 ◽

2020 ◽

Vol 80 (4) ◽

pp. 401-415 ◽

Cited By ~ 7

Author(s):

Juliette Palle ◽

Adrien Rochand ◽

Simon Pernot ◽

Claire Gallois ◽

Julien Taïeb ◽

...

Keyword(s):

Gastric Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Advanced Gastric Cancer ◽

Current Knowledge ◽

Growth Factor Receptor ◽

Future Perspectives ◽

Trastuzumab in combination with paclitaxel enhances antitumor activity by promoting apoptosis in human epidermal growth factor receptor 2-positive trastuzumab-resistant gastric cancer xenograft models

Anti-Cancer Drugs ◽

10.1097/cad.0000000000000853 ◽

2020 ◽

Vol 31 (3) ◽

pp. 241-250

Author(s):

Sei Shu ◽

Yoriko Yamashita-Kashima ◽

Mieko Yanagisawa ◽

Hayao Nakanishi ◽

Yasuhiro Kodera ◽

...

Keyword(s):

Gastric Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Antitumor Activity ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Xenograft Models ◽

Gastric Cancer Xenograft